Listed

Axil Brands, Inc.: Form 10-Q for the period ended Feb 29, 2024

Filed with the SEC on Apr 9, 2024 and accepted by EDGAR at Apr 9, 2024, 20:30 ET.

Share

Management's discussion and analysis

As filed, 22,826 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

The following Management’s Discussion and Analysis of Financial Condition and Results of Operations should be read in conjunction with, and is qualified in its entirety by, the unaudited consolidated financial statements and related notes thereto included in Item 1 in this Quarterly Report on Form 10-Q and with our audited consolidated financial statements and related notes included in our Annual Report on Form 10-K for the year ended May 31, 2023 filed with the SEC on August 21, 2023. Our Management’s Discussion and Analysis of Financial Condition and Results of Operations contains not only statements that are historical facts, but also statements that are forward-looking.

Although the forward-looking statements in this Quarterly Report on Form 10-Q reflect the good faith judgment of our management, such statements can only be based on facts and factors currently known by them. Consequently, and because forward-looking statements are inherently subject to risks and uncertainties, the actual results and outcomes may differ materially from the results and outcomes discussed in the forward-looking statements. You are urged to carefully review and consider the various disclosures made by us in herein and in our other reports as we attempt to advise interested parties of the risks and factors that may affect our business, financial condition, and results of operations and prospects. Please see “Cautionary Note Regarding Forward-Looking Statements” in this Quarterly Report on Form 10-Q for additional information.

Overview

The Company is engaged in the manufacturing, marketing, sale and distribution of high-tech, innovative hearing and audio enhancement and protection products that provide cutting-edge solutions for people with varied applications across many industries and professional quality hair and skin care products under various trademarks and brands.

As part of the Company’s ongoing rebranding efforts, the Company changed its name from Reviv3 Procare Company to AXIL Brands, Inc. effective February 14, 2024. On February 14, 2024, the Company successfully completed efforts to uplist (the “Uplist Transaction”) from the over-the-counter, or OTC, markets to the NYSE American exchange (“NYSE American”).

On May 1, 2022, we entered into an Asset Purchase Agreement dated May 1, 2022 and amended on June 15, 2022 and September 8, 2022 with AXIL & Associated Brands, a leader in hearing protection and enhancement products, for the acquisition of both the hearing protection business of AXIL & Associated Brands consisting of ear plugs and ear muffs, and AXIL & Associated Brands’ ear bud business. These businesses constituted substantially all of the business operations of AXIL & Associated Brands. The acquisition was completed subsequently on June 16, 2022. On September 8, 2022, the Company and AXIL & Associated Brands entered into an amendment to the Asset Purchase Agreement which eliminated the provision in the Asset Purchase Agreement requiring the Company to effectuate a reverse stock split of our common stock and preferred stock pursuant to the Asset Purchase Agreement within a certain period of time.

Effective as of January 16, 2024, the Company filed a Certificate of Amendment to the Company’s Amended and Restated Articles of Incorporation with the Delaware Secretary of State to implement the reverse stock split of the Company’s issued shares of common stock at a ratio of 1-for-20 approved by the Board of Directors. The reverse stock split did not affect the total number of shares of common stock that the Company is authorized to issue and any fractional shares remaining after the Reverse Stock Split were rounded up to the nearest whole share. The accompanying financial statements and notes to the financial statements give retroactive effect to the Reverse Stock Split for all periods presented, unless otherwise specified.

As a result of the acquisition of AXIL & Associated Brands’ assets, the Company has two reportable segments: hair care and skin care, and hearing enhancement and protection.

Through our hearing enhancement and protection segment, we design, innovate, engineer, manufacture, market and service specialized systems in hearing enhancement, hearing protection, wireless audio, and communication. Through our hair care and skin care segment, we manufacture, market, sell, and distribute professional quality hair and skin care products.

The Company’s overall business strategy is to establish market awareness of our products through our direct-to-consumer campaigns. We believe the increase in awareness will allow the Company to increase distribution and gain customers through our distribution partners’ retail establishments, with the goal of helping us achieve growth in market share and diversify our sales channels.

Results of Operations

Our results of operations are summarized below.

Nine Months Ended February 29, 2024 February 28, 2023 Three Months Ended February 29, 2024 February 28, 2023
Sales, net $20,997,289 $16,625,818 $6,469,343 $5,656,461
Cost of sales 5,467,458 4,085,645 1,845,017 1,437,976
Gross profit 15,529,831 12,540,173 4,624,326 4,218,485
Total operating expenses 14,196,041 11,139,189 4,728,205 4,001,897
Income (Loss) from operations 1,333,790 1,400,984 (103,879) 216,588
Net income $1,953,618 $1,064,475 $781,091 $162,048

For the Nine Months Ended February 29, 2024 Compared to the Nine Months Ended February 28, 2023

Net sales for the nine months ended February 29, 2024 and February 28, 2023 were $20,997,289 and $16,625,818, respectively. Net sales for the nine months ended February 29, 2024 increased by $4,371,471 or 26.3%, as compared to the nine months ended February 28, 2023. The increase was driven primarily by an increase in marketing campaign spend and strength in our sales channels for the Company’s products.

Cost of sales primarily includes the cost of products and freight-in costs. For the nine months ended February 29, 2024, the overall cost of sales increased by $1,381,813 or 33.8%, as compared to the comparable period ended February 28, 2023, which was primarily due to the relative increase in sales of Company products. Cost of sales as a percentage of net revenues for the nine months ended February 29, 2024 was 26.0% as compared to 24.6% for the comparable period in 2023. The marginal increase in cost of sales, as a percentage of sales, was primarily attributable to higher transportation costs and lower margin product sales. The Company will continue to work to increase efficiencies in procurement and logistics, as well as focus on enhanced production capabilities.

Gross profit for the nine months ended February 29, 2024 and February 28, 2023 was $15,529,831 and $12,540,173, respectively. Gross profit as a percentage of sales for the nine months ended February 29, 2024, was 74.0% as compared to 75.4% for the same comparable period in 2023. The decrease in the gross profit margin for the nine months ended February 29, 2024 was primarily attributable to an increase in sales of lower margin products in both our segments, partially offset by a decrease in discounts in our sales of AXIL products.

Operating expenses consisted of marketing and selling expenses, compensation and related taxes, professional and consulting fees, and general and administrative costs. Operating expenses increased by $3,056,852 or 27.4% from $11,139,189 for the nine months ended February 28, 2023 to $14,196,041 for the nine months ended February 29, 2024. Operating expenses as a percentage of net sales for the nine months ended February 29, 2024 were 67.6% compared to 67.0% for the comparable period in 2023. Operating expenses increased primarily due to a net increase in advertising and marketing expenses by $2,028,313 for expansion of current marketing campaigns and costs attributable to new product awareness, and a net increase of $891,181 for business general and administrative costs. The increase in general and administrative costs was primarily attributed to the increase in public related costs associated with our Uplist Transaction. Additionally, there was an increase of $638,067 for professional and consulting expenses to enhance existing business processes. This increase was partially offset by the optimization of our workforce resulting in an overall reduction of $500,709 for compensation and related taxes for the nine months ended February 29, 2024 as compared to the comparable period in 2023.

Income from operations for the nine months ended February 29, 2024 and February 28, 2023 was $1,333,790 and $1,400,984, respectively. The decrease in income from operations for the nine months ended February 29, 2024, of $67,194 or 4.8% compared to the nine months ended February 28, 2023, was primarily driven by the increase in professional and compliance expenses due to the Uplist Transaction and an increase in sales of lower margin products.

For the nine months ended February 29, 2024 the provision for income taxes amounted to a benefit of $397,054, that was related to the reversal of fiscal year ended May 31, 2023 income tax liability due to filing of the federal and state tax returns, as well as additional net operating losses which can offset current year income tax liability. In addition, there are remaining net operating losses that created a deferred tax asset which management believes are fully realizable. Provision for income tax expense was $395,344 for the nine months ended February 28, 2023.

As a result of the above, we reported a net income of $1,953,618 and $1,064,475, for the nine months ended February 29, 2024 and February 28, 2023, respectively, an increase of $889,143.

For the Three Months Ended February 29, 2024 Compared to the Three Months Ended February 28, 2023

Net sales for the three months ended February 29, 2024 and February 28, 2023 were $6,469,343 and $5,656,461, respectively. Net sales for the three months ended February 29, 2024 increased by $812,882 or 14.4%, as compared to the three months ended February 28, 2023, due to the increase in marketing campaign spend and strength in our sales channels for AXIL products.

For the three months ended February 29, 2024, the overall cost of sales increased by $407,041 or 28.3%, as compared to the three months ended February 28, 2023, which was also primarily due to the relative increase in sales of the Company’s products. Cost of sales as a percentage of net revenues for the three months ended February 29, 2024 was 28.5% as compared to 25.4% for the comparable period in 2023. The marginal increase in cost of sales, as a percentage of sales, was primarily attributable to an increase in transportation costs. The Company will continue to work to increase efficiencies in procurement and logistics.

Gross profit for the three months ended February 29, 2024 and 2023 was $4,624,326 and $4,218,485, respectively. Gross profit as a percentage of sales for the three months ended February 29, 2024, was 71.5% as compared to 74.6% for the comparable period in 2023. The decrease in the gross profit margin for the nine months ended February 29, 2024 was primarily attributable to an increase in sales of lower margin products in both our segments, partially offset by a decrease in discounts in our sales of AXIL products.

Operating expenses consisted of marketing and selling expenses, compensation and related taxes, professional and consulting fees, and general and administrative costs. Operating expenses increased by $726,308 or 18.1% from $4,001,897 in the three months ended February 28, 2023 to $4,728,205 in the three months ended February 29, 2024. Operating expenses as a percentage of net revenues for the three months ended February 29, 2024, were 73.1% compared to 70.7% for the three months ended February 29, 2024. The increase in operating expenses related primarily to a net increase in advertising and marketing expenses of $225,566 for expansion of current marketing campaigns and costs attributable to new product awareness, and a net increase of $336,235 for professional and consulting expenses and to enhance existing business processes. General and administrative costs increased by $296,440 primarily due to an increase in public related costs associated with our Uplist Transaction. This increase was partially offset by the optimization of our workforce resulting in an overall reduction of $131,933 for compensation and related taxes for the three months ended February 29, 2024 as compared to three months ended February 28, 2023.

Loss from operations for the three months ended February 29, 2024 was $103,879 compared to income of $216,588 for the three months ended February 28, 2023. The decrease in income from operations of $320,467 or (148.03%) was primarily related to the increase in operating costs related to our Uplist Transaction and expanded marketing campaign as well as the increased sales of lower margin products partially offset by a decrease in discounts.

For the three months ended February 29, 2024 provision for income taxes amounted to a benefit of $827,436 that was related to the reversal of fiscal year ended May 31, 2023 income tax liability due to filing of the federal and state tax returns, as well as additional net operating losses which can offset current year income tax liability. In addition, there are remaining net operating losses that created a deferred tax asset which management believes are fully realizable. For the three months ended February 28, 2023, provision for income tax expense was $59,547.

As a result of the above, we reported a net income of $781,091 and $162,048 for the three months ended February 29, 2024 and three months ended February 28, 2023, respectively, an increase of $619,043 or 382.0%.

Liquidity and Capital Resources

We are currently engaged in product sales and development. Although we earned a net income in the nine months ended February 29, 2024, we have incurred operating losses in the past. We currently expect to earn net income during the current fiscal year ending May 31, 2024. We believe our current cash balances, coupled with anticipated cash flow from operating activities, will be sufficient to meet our working capital requirements for at least one year from the date of issuance of the accompanying unaudited consolidated financial statements. We intend to continue to control our cash expenses as a percentage of expected revenue on an annual basis and thus may use our cash balances in the short-term to invest in revenue growth. As a result of the acquisition of AXIL & Associated Brands’ assets, we have generated and expect we will continue to generate sufficient cash for our operational needs, including any required debt payments, for at least one year from the date of issuance of the accompanying unaudited consolidated financial statements. Management is focused on growing the Company’s existing product lines, introducing new products, as well as expanding its customer base, to increase its revenues. The Company cannot give assurance that it can increase its cash balances or limit its cash consumption and thus maintain sufficient cash balances for its planned operations or future acquisitions. Future business demands, including those resulting from the purchase of AXIL & Associated Brands’ assets in June 2022, may lead to cash utilization at levels greater than recently experienced. The Company cannot provide any assurance that it will be able to raise additional capital or obtain necessary financing on acceptable terms, or at all. Subject to the foregoing, management believes that the Company has sufficient capital and liquidity to fund its operations for at least one year from the date of issuance of the accompanying unaudited consolidated financial statements.

Cash Flows

Operating Activities

Net cash provided by operating activities for the nine months ended February 29, 2024 was $339,323, attributable to a net income of $1,953,618, items of adjustments to depreciation and amortization, bad debts, gain on settlement, benefit for deferred income taxes and stock based compensation that total $87,894. There were favorable changes in accounts payable and accrued expenses of $1,061,420 and prepaid expenses and other current assets of $145,032 offset primarily by an increase of inventory of $2,131,429.

Net cash flows provided by operating activities for the nine months ended February 28, 2023 was $2,319,976, attributable to net income of $1,064,475, depreciation and amortization of $66,944, provision for bad debts of $13,782, stock based compensation expense of $155,067, gain on settlement of debt of $50,500, and net change in operating assets and liabilities of $1,070,209 primarily due to an increase in accounts receivables, increase in prepaid expenses, increase in security deposit offset by a decrease of inventory, an increase in accounts payable, increase in other current liabilities and increase in contract liabilities.

Investing Activities

Net cash flows used in investing activities for the nine months ended February 29, 2024 was $80,192 due to the purchase of property and equipment for the Company’s business. For the nine months ended February 28, 2023, net cash flows provided were $1,000,764, attributable to the cash received from acquisition of the AXIL & Associated Brands business and partially offset by the purchase of property and equipment of $65,650 during the same period.

Financing Activities

Net cash flows used in financing activities for the nine months ended February 29, 2024 was $204,246, and were for repayment of equipment financing and note payable, and a prepayment made to a related party. Net cash flows provided by financing activities for the nine months ended February 28, 2023, amounted to $485,861, primarily resulting from the Company’s capital raise of $447,850 pursuant to a private placement of shares of common stock, including receipt of $63,008 in related party loans, and repayment of loans that totaled $24,997.

During the nine months ended February 29, 2024, the Company has various financed items and has debt outstanding in order to run the Company’s business operations.

As of February 29, 2024, we had a secured Economic Injury Disaster Loan outstanding, administered pursuant to the CARES Act in the principal amount of $147,150, with a maturity date of May 18, 2050. The Company continues to pay interest on the loan.

We are dependent on our product sales to fund our operations and may require additional capital in the future, such as pursuant to the sale of additional common stock or of debt securities or entering into credit agreements or other borrowing arrangements with institutions or private individuals, to maintain operations, which may not be available on favorable terms, or at all, and could require us to sell certain assets or discontinue or curtail our operations. If the current equity and credit markets deteriorate, it may make any necessary debt or equity financing more difficult, more costly and more dilutive. In addition, pursuant to a voting agreement, effective June 16, 2022, with AXIL & Associated Brands and Intrepid Global Advisors, Inc., we are subject to certain limitations on our ability to sell our capital stock until June 2024. Our officers and directors have made no written commitments with respect to providing a source of liquidity in the form of cash advances, loans, and/or financial guarantees. We do not have any plans to seek additional financing at this time and anticipate that our existing cash equivalents and cash provided by operations will be sufficient to meet our working capital requirements. However, if the need arises for additional cash, there can be no assurance that we will be able to raise the capital we need for our operations on favorable terms, or at all. We may not be able to obtain additional capital or generate sufficient revenues to fund our operations. Failure to secure any necessary financing in a timely manner and on favorable terms could have a material adverse effect on our growth strategy, financial performance and stock price and could require us to delay or abandon our business plans. If we are unsuccessful at raising sufficient funds, for whatever reason, to fund our operations, we may be forced to cease operations. If we fail to raise funds, we expect that we will be required to seek protection from creditors under applicable bankruptcy laws.

Off-Balance Sheet Arrangements

As of February 29, 2024, we do not have any off-balance sheet arrangements that have or are reasonably likely to have a current or future effect on our financial condition, changes in financial condition, revenues or expenses, results or operations, liquidity, capital expenditures or capital resources that is material to investors.

Critical Accounting Policies

The preparation of condensed consolidated financial statements in conformity with accounting principles generally accepted in the United States of America requires us to make a number of estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements. Such estimates and assumptions affect the reported amounts of expenses during the reporting period. On an ongoing basis, we evaluate estimates and assumptions based upon historical experience and various other factors and circumstances. We believe our estimates and assumptions are reasonable in the circumstances; however, actual results may differ from these estimates under different future conditions.

We believe that the estimates and assumptions that are most important to the portrayal of our financial condition and results of operations, in that they require the most difficult, subjective or complex judgments, form the basis for the accounting policies deemed to be most critical to us. These critical accounting policies relate to revenue recognition, impairment of intangible assets and long-lived assets, inventory, stock compensation, and evaluation of contingencies. We believe estimates and assumptions related to these critical accounting policies are appropriate under the circumstances; however, should future events or occurrences result in unanticipated consequences, there could be a material impact on our future financial condition or results of operations.

See the footnotes to our unaudited consolidated financial statements for the three and nine months ended February 29, 2024, included with this Quarterly Report on Form 10-Q for additional discussion of our critical accounting policies and use of estimates.

Controls and procedures

As filed, 4,486 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

Disclosure Controls and Procedures

We maintain “disclosure controls and procedures,” as such term is defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act, that are designed to ensure that information required to be disclosed in our Exchange Act reports is recorded, processed, summarized and reported within the time periods specified in the SEC rules and forms, and that such information is accumulated and communicated to our management, including our Chief Executive Officer (“CEO”) and Principal Executive Officer, and Chief Financial Officer (“CFO”) and Principal Financial and Accounting Officer, as appropriate, to allow timely decisions regarding required disclosure. We conducted an evaluation, under the supervision and with the participation of our CEO and CFO, of the effectiveness of the design and operation of our disclosure controls and procedures as of February 29, 2024. Based on this evaluation of disclosure controls and procedures as of February 29, 2024, our CEO and CFO concluded that our disclosure controls and procedures were not effective.

Internal Control over Financial Reporting

Our management is responsible for establishing and maintaining adequate internal control over financial reporting, as such term is defined in Exchange Act Rules 13a-15(f) and 15(d)-15(f). Our internal control over financial reporting is a process designed to provide reasonable assurance to our management and the Board regarding the reliability of financial reporting and the preparation of the financial statements for external purposes in accordance with accounting principles generally accepted in the United States of America. Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.

Our management, including our CEO and CFO, assessed the effectiveness of our internal control over financial reporting as of February 29, 2024 using criteria set forth by the Committee of Sponsoring Organizations of the Treadway Commission Internal Control-Integrated Framework issued in 2013. Based on the assessment, our management has concluded that as of February 29, 2024, our internal control over financial reporting was not effective based on those criteria.

Remediation

The Company plans to initiate measures to improve the effectiveness of the internal controls over financial reporting and disclosure controls and procedures. We are working with a third-party to enhance the reporting in our accounting systems, as well as increase the level of review when any non-routine accounting entry is proposed. The Company hired additional accounting personnel during the period ended February 29, 2024, to oversee the financial close and reporting process. The Company plans to hire additional staff to aid in segregation of duties to continue to improve our internal controls in the coming fiscal year. We have also started to develop an internal control structure and identify key procedures for financial reporting as required by Section 404 of the Sarbanes-Oxley Act of 2002 and we are currently in the process of documenting our internal control policies and procedures. During the period ended February 29, 2024 we adopted written policies and procedures that were distributed to employees for review and approval by the Board, and we anticipate will be fully implemented during the fiscal year ending May 31, 2024. In addition, the Company has adopted controls related to corporate governance, including a Code of Business Conduct and Ethics that applies to all of our employees, including our CEO and CFO, and to the Board.

Changes in Internal Control over Financial Reporting

Other than as described under “Remediation” above, there has been no change in our internal control over financial reporting identified in connection with the evaluation required by Rules 13a-15(d) or 15d-15(d) under the Exchange Act that occurred during the fiscal quarter ended February 29, 2024 that has materially affected or is reasonably likely to materially affect our internal control over financial reporting. Our management is currently taking corrective action to remedy the internal control weaknesses. See section entitled “Remediation” above.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2024-02-29. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Revenue3 months2023-12-01 to 2024-02-29$6.5mus-gaap:Revenues
Revenue9 months2023-06-01 to 2024-02-29$21.0mus-gaap:Revenues
Cost of revenue3 months2023-12-01 to 2024-02-29$1.8mus-gaap:CostOfGoodsAndServicesSold
Cost of revenue9 months2023-06-01 to 2024-02-29$5.5mus-gaap:CostOfGoodsAndServicesSold
Gross profit3 months2023-12-01 to 2024-02-29$4.6mus-gaap:GrossProfit
Gross profit9 months2023-06-01 to 2024-02-29$15.5mus-gaap:GrossProfit
Operating income3 months2023-12-01 to 2024-02-29−$103.9kus-gaap:OperatingIncomeLoss
Operating income9 months2023-06-01 to 2024-02-29$1.3mus-gaap:OperatingIncomeLoss
Interest expense3 months2023-12-01 to 2024-02-29$1.5kus-gaap:InterestExpense
Interest expense9 months2023-06-01 to 2024-02-29$4.8kus-gaap:InterestExpense
Income tax3 months2023-12-01 to 2024-02-29−$827.4kus-gaap:IncomeTaxExpenseBenefit
Income tax9 months2023-06-01 to 2024-02-29−$397.1kus-gaap:IncomeTaxExpenseBenefit
Net income3 months2023-12-01 to 2024-02-29$781.1kus-gaap:NetIncomeLoss
Net income9 months2023-06-01 to 2024-02-29$2.0mus-gaap:NetIncomeLoss
Diluted EPS3 months2023-12-01 to 2024-02-29$0.04us-gaap:EarningsPerShareDiluted
Diluted EPS9 months2023-06-01 to 2024-02-29$0.11us-gaap:EarningsPerShareDiluted
Basic EPS3 months2023-12-01 to 2024-02-29$0.13us-gaap:EarningsPerShareBasic
Basic EPS9 months2023-06-01 to 2024-02-29$0.33us-gaap:EarningsPerShareBasic
Diluted shares (weighted)3 months2023-12-01 to 2024-02-2918,576,914 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Diluted shares (weighted)9 months2023-06-01 to 2024-02-2918,569,140 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Operating cash flow9 months2023-06-01 to 2024-02-29$339.3kus-gaap:NetCashProvidedByUsedInOperatingActivities
Capital expenditure9 months2023-06-01 to 2024-02-29$80.2kus-gaap:PaymentsToAcquirePropertyPlantAndEquipment
Cash and equivalentsAt period end2024-02-29$4.9mus-gaap:CashAndCashEquivalentsAtCarryingValue
Current assetsAt period end2024-02-29$10.0mus-gaap:AssetsCurrent
Total assetsAt period end2024-02-29$12.7mus-gaap:Assets
Current liabilitiesAt period end2024-02-29$3.2mus-gaap:LiabilitiesCurrent
Total liabilitiesAt period end2024-02-29$3.9mus-gaap:Liabilities
Shareholders' equityAt period end2024-02-29$8.8mus-gaap:StockholdersEquity

Source: SEC EDGAR, the filing index for accession 0001520138-24-000162. Last ingested by Listed: Oct 24, 2026, 15:15 ET. Listed shows no prices and gives no investment advice.